HISUN(SH:600267) Ge Long Hui·2025-10-19 09:08Core Viewpoint - The announcement from Haizheng Pharmaceutical indicates that the European Union has lifted the non-compliance status of the company's Taizhou factory, which is expected to positively impact the company's product sales in the EU and other markets [1] Group 1 - Haizheng Pharmaceutical received official communication from the EU regarding the withdrawal of the non-compliance declaration for its Phase II project (Y20, Y36, Y37, Y38, and Y39) on October 17, 2025 [1] - The lifting of the GMP non-compliance status is a significant development for the company, enhancing its ability to sell products in the EU market [1] - This change is anticipated to have a positive effect on the company's overall market presence and sales performance [1]